By continuing to use this site, you agree to the use of cookies in accordance with our privacy policy.

Research Support

Medical Technology Enterprise Consortium (MTEC) – funding opportunities

March 5, 2024 at 12:30pm1:30pm EST

Virtual (See event details)

This event has already occurred. The information may no longer be valid.

Please join leaders from the Medical Technology Enterprise Consortium (MTEC) to learn more about potential funding opportunities.  The consortium focuses on the development of medical solutions that protect, treat, and optimize the health and performance of U.S. military personnel and civilians.

About MTEC

The Medical Technology Enterprise Consortium (MTEC) is a public-private partnership that is authorized to serve by the Department of Defense to promote the development and delivery of innovative medical technologies to improve the health and safety of military personnel, veterans, and civilians. MTEC is a 501(c)(3) biomedical technology consortium that is internationally-dispersed, collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement with the U.S. Army Medical Research and Development Command..


Dr. Lauren Palestrini, Chief Science Officer

Lauren Palestrini, Ph.D., is the Chief Science Officer at MTEC, where she serves as the lead technology officer within the medical product development activities, oversees the development of technology solutions that will meet industry commercialization targets, conducts initial technology assessments, and maintains adequate coverage of military clinical needs. Dr. Palestrini is also working on generating external funding streams through fundraising. Dr. Palestrini earned a Bachelor of Science Degree in Chemical Engineering from Cornell University, and a Doctoral Degree in Biomedical Engineering from Stony Brook University. Her graduate work focused on the development of a biodegradable, electrospun fiber mat for the topical delivery of a novel fibronectin-derived peptide for the limitation of burn injury progression. Until recently, she served as the Director of Research at the New Jersey Center for Biomaterials at Rutgers University where she managed a cross-disciplinary set of research projects in support of the Department of Defense-funded Armed Forces Institute of Regenerative Medicine (AFIRM) cooperative agreement within regenerative medicine. In addition, her prior experience includes process development at Regeneron Pharmaceuticals, research and development at Johnson & Johnson Consumer Products, and human resources at Deutsche Bank.


Kathy Zolman, Chief of Consortium Operations

Ms. Zolman’s responsibilities as MTEC Chief of Consortium Operations include management of all functions within consortium operations to include OTA execution, membership management, solicitation management, contracting, finance, marketing, and information technology oversight. She has an active role in customer relationships with military funding sponsors and membership. Previously Ms. Zolman was Director of Program Operations for MTEC, where she was an integral part in the growth of the consortium to over 600 members and awarded over $700M of government funding. Ms. Zolman has been instrumental in the startup, business management, day-to-day management, and planning for several collaborative initiatives at Advanced Technology International. She has over 20 years of progressive management experience in program and project management, business development, market research, and financial management. Ms. Zolman earned her undergraduate degree in International Business and Management from Penn State University and holds Spanish Minor from the Universidad de Salamanca, Spain. She has a Masters of International Business Administration from the University of South Carolina.


This event was published on February 20, 2024.

Event Details